Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Arrowhead Pharmaceuticals Inc. buy Chardan Capital

Arrowhead Pharmaceuticals Inc.
Start price
€25.07
08.08.23 / 50%
Target price
€54.73
08.08.24
Performance (%)
-10.25%
End price
€22.50
09.08.24
Summary
This prediction ended on 09.08.24 with a price of €22.50. The price of Arrowhead Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.25%. Chardan_Capital has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Arrowhead Pharmaceuticals Inc. 12.071% 12.071% 125.000%
iShares Core DAX® 0.142% -1.511% 18.159%
iShares Nasdaq 100 0.833% -2.600% 9.025%
iShares Nikkei 225® -0.829% -7.040% 10.142%
iShares S&P 500 0.008% -1.196% 3.094%

Comments by Chardan_Capital for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -10.25%
Target price 54.726
Change
Ends at 08.08.24

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $60.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat

Chardan Capital 
0
Report Share
08.08.23
In the thread Trading Arrowhead Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -10.25%
Target price 54.726
Change
Ends at 08.08.24

Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

Chardan Capital 
0
Report Share
09.08.24

Current prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc.

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€21.00
12.12.24
€57.21
12.12.25
170.19%
16:21

Chardan Capital 
12.12.24 50%

Stopped prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc.

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€44.10
01.12.25
€51.74
01.12.26
26.98%
16:21

Chardan Capital 
01.12.25 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€34.14
19.11.25
€51.83
19.11.26
64.03%
16:21

Chardan Capital 
19.11.25 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.60
13.05.25
€54.02
13.05.26
311.76%
16:21

Chardan Capital 
13.05.25 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€18.61
11.02.25
€58.10
11.02.26
204.97%
16:21

Chardan Capital 
11.02.25 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€23.09
27.11.24
€56.75
27.11.25
116.54%
28.11.25

Chardan Capital 
27.11.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.45
18.07.24
€54.83
18.07.25
-43.75%
19.07.25

Chardan Capital 
18.07.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.45
18.07.24
€54.83
18.07.25
-43.75%
19.07.25

Chardan Capital 
18.07.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.44
26.06.24
€56.18
26.06.25
-46.27%
27.06.25

Chardan Capital 
26.06.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€22.62
03.06.24
€55.13
03.06.25
-35.92%
04.06.25

Chardan Capital 
03.06.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€20.70
10.05.24
€55.70
10.05.25
-42.68%
11.05.25

Chardan Capital 
10.05.24 50%